Advertisement

Topic - Medtronic

Related Stories

Appeals court upholds $112 million verdict to Indiana doctor

Associated Press

Medtronic pays $9.2M to settle South Dakota kickback case

Associated Press

Biogen, AMC Entertainment rise; Levi Strauss, Ascena fall

Associated Press

Cleveland-Cliffs, CBL tumble while Lands’ End, ViewRay gain

Associated Press

Runner’s bib message turns out to be prophetic

Associated Press

Indiana doctor awarded $112M in Medtronic royalties dispute

Associated Press

This combination of Saturday, Aug. 25, 2018 photos shows demonstration models of implantable neurostimulators, top row from left, the Medtronic Intellis and the Boston Scientific Spectra WaveWriter SCS. Bottom row from left are the Abbott/St. Jude's Proclaim 7 Implantable Pulse Generator and Proclaim DRG Implantable Pulse Generator. For years, medical device companies and doctors have touted spinal cord stimulators as a panacea for millions of patients suffering from a wide range of intractable pain disorders. But the devices, surgically placed inside the back, that use electrical currents to block pain signals before they reach the brain _ are more dangerous than many patients understand, according to an Associated Press investigation. (AP Photo/Mary Altaffer)

Spinal-cord stimulators mean big business for device makers

By MITCH WEISS and HOLBROOK MOHR - Associated Press

In this Dec. 13, 2010 photo, Earl Bakken, an electronics repairman who started one of the world's largest medical device companies in 1949, poses at the Medtronic World Headquarters in Fridley, Minn. Medtronic said in a statement that co-founder Bakken died Sunday, Oct. 21, 2018, at his home in Hawaii. (David Brewster/Star Tribune via AP)

Medtronic co-founder who created wearable pacemaker dies

Associated Press

China rebukes Zara, Delta for calling Taiwan ‘country’

By JOE McDONALD - Associated Press

Connecticut teen pumped to pioneer high-tech diabetes device

By ED STANNARD - Associated Press

This image provided by Medtronic shows its MiniMed 670G system. Federal regulators have approved a first-of-a-kind &quot;artificial pancreas,&quot; a device that can help some diabetes patients manage their disease by constantly monitoring their blood sugar and delivering insulin as needed. The device from Medtronic was approved Wednesday, Sept. 28, 2016, for patients with Type 1 diabetes, the kind usually diagnosed during childhood. (Medtronic via AP)

FDA approves ‘artificial pancreas’ to manage diabetes

By MATTHEW PERRONE - Associated Press

This image provided by Medtronic shows its MiniMed 670G system. Federal regulators have approved a first-of-a-kind &quot;artificial pancreas,&quot; a device that can help some diabetes patients manage their disease by constantly monitoring their blood sugar and delivering insulin as needed. The device from Medtronic was approved Wednesday, Sept. 28, 2016, for patients with Type 1 diabetes, the kind usually diagnosed during childhood. (Medtronic via AP)

FDA approves ‘artificial pancreas’ to manage diabetes

By MATTHEW PERRONE - Associated Press